XML 56 R32.htm IDEA: XBRL DOCUMENT
v3.23.4

Stockholders’ Equity (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2023 | Dec. 31, 2022
Equity [Abstract] |  |
Schedule of Restricted Stock Activity |  | A summary of the restricted stock activity is presented as follows: Schedule of Restricted Stock Activity
|  |  |  |  | Weighted Average |
|  |  |  |  | Grant Date |
|  | Shares |  |  | Fair Value |
Outstanding at |  |  |  |  |  |  |  |
December 31, 2021 |  |  | 317,586 |  |  | $ | 3.27 |
Granted |  |  | 966,801 |  |  |  | 0.63 |
Vested |  |  | (405,542 | ) |  |  | 2.69 |
Forfeited |  |  | (35,000 | ) |  |  | 2.00 |
December 31, 2022 |  |  | 843,845 |  |  | $ | 0.56 |
Schedule of Stock Option Activity | Stock option transactions for the nine months ended September 30, 2023 and the year ended December 31, 2022 are summarized as follows: Schedule of Stock Option Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |  |  | Weighted |
|  |  |  |  | Weighted |  |  | Remaining |  |  |  |  |  | Average |
|  |  |  |  | Average |  |  | Contractual |  |  | Aggregate |  |  | Grant |
Stock Options |  | Number of Options |  |  | Exercise Price |  |  | Term (Years) |  |  | Intrinsic Value |  |  | Date Fair Value |
Outstanding - December 31, 2021 |  |  | 21,923 |  |  | $ | 14.24 |  |  |  | 3.25 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  | 21,923 |  |  | $ | 14.24 |  |  |  | 3.25 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2021 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Granted |  |  | 71,558 |  |  | $ | 5.59 |  |  |  |  |  |  |  |  |  |  | $ | 4.99 |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2022 |  |  | 93,481 |  |  | $ | 7.62 |  |  |  | 3.68 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2022 |  |  | 64,823 |  |  | $ | 8.45 |  |  |  | 3.47 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2022 |  |  | 28,658 |  |  | $ | 5.74 |  |  |  | 4.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | 254,824 |  |  | $ | 6.97 |  |  |  |  |  |  |  |  |  |  | $ | 0.29 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | (348,306 | ) |  | $ | 7.14 |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - September 30, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - September 30, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - September 30, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  | $ | - |
| The following table represents option activity during the year ended December 31, 2022: Schedule of Stock Option Activity
|  | Number of |  |  | Weighted Average |  |  | Weighted Average Remaining Contractual Term |
|  | Options |  |  | Exercise Price |  |  | (years) |
Outstanding at December 31, 2021 |  |  | 175,384 |  |  | $ | 1.78 |  |  |  | 3.3 |
Options granted |  |  | 572,462 |  |  |  | 1.26 |  |  |  | 7.0 |
Outstanding at December 31, 2022 |  |  | 747,846 |  |  | $ | 1.36 |  |  |  | 4.2 |
Exercisable at December 31, 2022 |  |  | 428,962 |  |  | $ | 1.46 |  |  |  | 3.4 |
Schedule of Fair Value Assumptions | The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions: Schedule of Fair Value Assumptions
Expected term (years) |  |  | 5.00 |
Expected volatility |  |  | 59% - 62 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 4.00 | %
Expected term (years) |  |  | 5.00 |
Expected volatility |  |  | 62 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 1.64 | %
| Schedule of Fair Value Assumptions
|  | Year Ended December 31, 2022 |
Valuation assumptions: |  |  |  |
Risk-free rate |  |  | 1.64 | %
Expected volatility |  |  | 62 | %
Expected term (years) |  |  | 5 |
Dividend yield |  |  | 0 |
Schedule of Company Nonvested Shares | A summary of the Company’s nonvested shares (due to service based restrictions) as of September 30, 2023 and December 31, 2022, is presented below: Schedule of Company Nonvested Shares
|  |  |  |  | Weighted Average |
|  | Number of |  |  | Gant Date |
Non-Vested Shares |  | Shares |  |  | Fair Value |
Balance - December 31, 2021 |  |  | 39,698 |  |  | $ | 26.16 |
Granted |  |  | 120,850 |  |  |  | 5.04 |
Vested |  |  | (50,693 | ) |  |  | 21.52 |
Cancelled/Forfeited |  |  | (4,375 | ) |  |  | 16.00 |
Balance - December 31, 2022 |  |  | 105,481 |  |  |  | 0.56 |
Granted |  |  | 836,800 |  |  |  | 2.33 |
Vested |  |  | (196,594 | ) |  |  | 2.90 |
Cancelled/Forfeited |  |  | (23,379 | ) |  |  | 2.21 |
Balance - September 30, 2023 |  |  | 722,308 |  |  | $ | 0.71 |
Schedule of Stock Warrant Activity | Warrant activity for the nine months ended September 30, 2023 and the year ended December 31, 2022 are summarized as follows: Schedule of Stock Warrant Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2021 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 3.22 |  |  | $ | - |
Vested and Exercisable - December 31, 2021 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 3.22 |  |  | $ | - |
Unvested - December 31, 2021 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - December 31, 2022 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 2.22 |  |  | $ | 82,756 |
Vested and Exercisable - December 31, 2022 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 2.22 |  |  | $ | 82,756 |
Unvested - December 31, 2022 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - September 30, 2023 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 1.48 |  |  | $ | 159,271 |
Vested and Exercisable - September 30, 2023 |  |  | 203,629 |  |  | $ | 4.15 |  |  |  | 1.48 |  |  | $ | 159,271 |
Unvested and non-exercisable - September 30, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration